Clicky

JB Chemicals & Pharmaceuticals Limited(JBCHEPHARM)

Description: J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.


Keywords: Diabetes Medication Active Pharmaceutical Ingredients X Ray Ultrasound Contract Manufacturing Services Hypertension Magnetic Resonance Imaging MRI Anti Infectives Herbal Medicine Dosage Form Pharmaceutical Formulations Pharmaceutical Industry In Bangladesh Contrast Media Cetirizine Active Ingredient Ciprofloxacin Contrast Media Products Diclofenac Sodium Nifedipine Herbal Remedies Industry In Bangladesh Pharmaceutical Dosage Forms

Home Page: www.jbpharma.com

Cnergy IT Park
Mumbai, 400025
India
Phone: 91 22 2439 5200


Officers

Name Title
Mr. Nikhil Ashokkumar Chopra CEO & Whole-Time Director
Suresh Amin Assistant Vice President ? Human Resource
Mr. Narayan Saraf Chief Financial Officer
Mr. Kunal Khanna President of Operations
Mr. Bhagwat Singh Deora Vice President of Finance & Accounts
Mr. Suresh Bhise Vice President of Information & Technology
Mr. Sridhar Bharadwaj Vice President of HR & Administration
Mr. Himanshu Ranvah Vice President of Legal
Mr. Pradeep Kumar Singh President of Global Business
Mr. Parmeshwar B. Bang Executive Vice President of Operations of Daman

Exchange: NSE

Country: IN : India

Currency: Indian Rupee (INR)

Forward PE: 21.692
Trailing PE: 45.8765
Price-to-Book MRQ: 8.5398
Price-to-Sales TTM: 7.3734
IPO Date:
Fiscal Year End: March
Full Time Employees: 5311
Back to stocks